ONO PHARMACEUTICAL CO., LTD.
JapanMANUFACTURING2024
Scope 1
6,700
t CO₂e
Scope 2
Market-based
9,500
t CO₂e
Scope 3
38,600
t CO₂e
Total Emissions
54,800
t CO₂e
* Absolute value not specified in source report
Deloitte Tohmatsu Sustainability LLC.(limited assurance)
Scope 3 Category Breakdown
| Category | Emissions (t CO₂e) |
|---|---|
| 1.Purchased Goods & Services | Included in total* |
| 2.Capital Goods | 18,400 |
| 3.Fuel & Energy Related Activities | 2,900 |
| 4.Upstream Transportation | 200 |
| 5.Waste Generated in Operations | 300 |
| 6.Business Travel | 3,100 |
| 7.Employee Commuting | 700 |
| 8.Upstream Leased Assets | 1,900 |
| 9.Downstream Transportation | Included in total* |
| 12.End-of-Life Treatment | 200 |
| 13.Downstream Leased Assets | 300 |
* Absolute value not specified in source report
Roundarc Dataset
Need revenue-based emission factors for supply chain calculations? The full dataset includes emission intensity per dollar of revenue, financial data, SBTI targets, and more for every company.
This data is provided for informational and research purposes only and may not be used commercially without a licence. Contact [email protected] for licensing.